Related Experiment Video
Updated: Feb 27, 2026

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Therapeutic Approaches to Treat SARS-CoV-2
Lekhnath Sharma1, Neelesh Maheshwari2, Nupur Maheshwari3
1Department of Chemistry, Indian Institute of Technology Indore, Khandwa Road, Simrol, Indore, Madhya Pradesh, 453552, India.
This review details severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) treatments, covering pathogenesis, prevention, diagnosis, and clinical characteristics. It highlights key drug targets and discovered therapeutics for COVID-19 management.
Area of Science:
- Virology
- Infectious Diseases
- Pharmacology
Background:
- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) caused a global pandemic, necessitating rapid development of therapeutic strategies.
- Initial FDA approval of remdesivir marked early efforts in COVID-19 treatment.
- Understanding SARS-CoV-2 protein targets is crucial for effective prevention and treatment.
Purpose of the Study:
- To provide a comprehensive overview of SARS-CoV-2 pathogenesis, prevention, diagnosis, and clinical features.
- To detail potential drug targets within SARS-CoV-2 and host proteins.
- To review currently available and emerging treatment options worldwide.
Main Methods:
- Literature review and analysis of scientific publications on SARS-CoV-2.
- Examination of the structure and function of key viral and host proteins.
- Compilation of data on drug screening, repurposing, and clinical trial outcomes.
Main Results:
- Identification of critical SARS-CoV-2 targets: spike protein, main protease, papain-like protease, RNA-dependent RNA polymerase, ACE2, and TMPRSS2.
- Discovery of multiple therapeutic agents through screening and repurposing, including nirmatrelvir-ritonavir, remdesivir, molnupiravir, anakinra, vilobelimab, baricitinib, and tocilizumab.
- Summary of global treatment options and their efficacy.
Conclusions:
- Effective management of COVID-19 requires a multi-faceted approach including prevention, early diagnosis, and targeted therapies.
- Ongoing research into viral pathogenesis and drug development is essential for combating SARS-CoV-2.
- A range of pharmaceutical interventions are available, with continuous evaluation of their clinical utility.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Microorganisms in Medicine and Therapeutics
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

